We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$314M
2
DT icon
Dynatrace
DT
+$312M
3
CSGP icon
CoStar Group
CSGP
+$301M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$249M
5
CLVT icon
Clarivate
CLVT
+$237M

Top Sells

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$411M
2
RTX icon
RTX Corp
RTX
+$335M
3
CERN
Cerner Corp
CERN
+$312M
4
AVGO icon
Broadcom
AVGO
+$257M
5
PLAN
Anaplan, Inc.
PLAN
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 30.97%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWTR
26
DELISTED
Twitter, Inc.
TWTR
$274M 1.49%
+7,325,000
New +$314M
ADBE icon
27
Adobe
ADBE
$109B
$260M 1.41%
710,772
+4,400
+0.6% +$1.79M
BX icon
28
Blackstone
BX
$108B
$257M 1.4%
2,821,451
-102,000
-3% -$11M
AON icon
29
Aon
AON
$75.3B
$250M 1.36%
928,486
-85,500
-8% -$24.6M
SHW icon
30
Sherwin-Williams
SHW
$84.1B
$238M 1.29%
1,062,592
-162,500
-13% -$41.7M
CHNG
31
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$234M 1.27%
10,165,000
+6,891,400
+211% +$161M
NOW icon
32
ServiceNow
NOW
$133B
$233M 1.26%
2,450,750
-11,000
-0.4% -$1.05M
EXEL icon
33
Exelixis
EXEL
$13.4B
$212M 1.15%
10,174,273
-345,788
-3% -$7.13M
NYT icon
34
New York Times
NYT
$10.6B
$192M 1.04%
6,880,804
-457,550
-6% -$16.5M
BEKE icon
35
KE Holdings
BEKE
$19.6B
$179M 0.97%
9,958,500
+1,245,000
+14% +$17.5M
XYZ
36
Block Inc
XYZ
$49.4B
$174M 0.95%
2,839,000
+643,000
+29% +$58.8M
AVTR icon
37
Avantor
AVTR
$9.78B
$164M 0.89%
5,279,464
+1,472,352
+39% +$46M
COHR
38
DELISTED
Coherent Inc
COHR
$154M 0.83%
577,982
+106,449
+23% +$28.5M
JAZZ icon
39
Jazz Pharmaceuticals
JAZZ
$16.5B
$144M 0.78%
920,100
+591,100
+180% +$91M
LU icon
40
Lufax Holding
LU
$1.2B
$142M 0.77%
5,935,100
+426,500
+8% +$9.9M
BEAM icon
41
Beam Therapeutics
BEAM
$3.07B
$134M 0.73%
3,472,271
+877,884
+34% +$34.9M
LH icon
42
Labcorp
LH
$27.3B
$122M 0.66%
603,783
+103,247
+21% +$22M
CVS icon
43
CVS Health
CVS
$119B
$115M 0.63%
1,246,259
+59,976
+5% +$5.85M
VMW
44
DELISTED
VMware, Inc
VMW
$115M 0.62%
+1,010,000
New +$115M
ALNY icon
45
Alnylam Pharmaceuticals
ALNY
$31.6B
$115M 0.62%
787,910
-235,963
-23% -$33.5M
SPGI icon
46
S&P Global
SPGI
$127B
$111M 0.6%
+329,000
New +$117M
MANT
47
DELISTED
Mantech International Corp
MANT
$92.7M 0.5%
971,595
+596,595
+159% +$53.3M
UTHR icon
48
United Therapeutics
UTHR
$22B
$92.5M 0.5%
392,696
+13,000
+3% +$2.64M
TSM icon
49
TSMC
TSM
$2.17T
$92.1M 0.5%
1,126,125
+98,000
+10% +$9.06M
SRPT icon
50
Sarepta Therapeutics
SRPT
$1.98B
$88.8M 0.48%
1,185,051
+193,076
+19% +$14.2M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2022 Portfolio in Review

As of Q2 2022, Thomas Steyer held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Twitter, Inc. worth $274M.

  • Thomas Steyer's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Thomas Steyer added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Thomas Steyer's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Thomas Steyer fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Thomas Steyer's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Thomas Steyer opened 22 new positions and closed 30 in Q2 2022.
  • Thomas Steyer's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.